packagePonatinib

ponatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ponatinib is a tyrosine-kinase inhibitor used to treat certain leukemias, including myeloid and lymphoid forms. It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q198728 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ponatinib
ATC codes:L01EA05
DrugBank:DB08901
PubChem CID:24826799
ChEBI:78543
Wikidata:Q198728
formula:C29H27F3N6O
molar mass:532.57 g/mol (PubChem CID 24826799)
logP:4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown